Desidustat
- Generic Name
- Desidustat
- Drug Type
- Small Molecule
- Chemical Formula
- C16H16N2O6
- CAS Number
- 1616690-16-4
- Unique Ingredient Identifier
- Y962PQA4KS
- Background
Desidustat is under investigation in clinical trial NCT04012957 (Desidustat in the Treatment of Anemia in CKD).
A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
Phase 4
Recruiting
- Conditions
- Chronic Kidney DiseasesAnemia of Chronic Kidney Disease
- Interventions
- First Posted Date
- 2022-08-25
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Zydus Lifesciences Limited
- Target Recruit Count
- 1004
- Registration Number
- NCT05515367
- Locations
- 🇮🇳
Indira Gandhi Institute of Medical Sciences, Sheikhpura, Bihar, India
Desidustat in the Treatment of Chemotherapy Induced Anemia
Phase 1
Completed
- Conditions
- Anemia of Chronic Kidney DiseaseChemotherapy Effect
- Interventions
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Zydus Lifesciences Limited
- Target Recruit Count
- 24
- Registration Number
- NCT04667533
- Locations
- 🇮🇳
HCG Manavata Cancer Centre,, Nashik, Mahar Ashtra, India
Desidustat in the Management of COVID-19 Patients
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- Zydus Lifesciences Limited
- Target Recruit Count
- 24
- Registration Number
- NCT04463602
- Locations
- 🇲🇽
Avant Sante Site 1, Monterrey, Mexico
Desidustat in the Treatment of Anemia in CKD on Dialysis Patients
Phase 3
Completed
- Conditions
- Chronic Kidney Disease Stage 5 on Dialysis
- Interventions
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- Zydus Lifesciences Limited
- Target Recruit Count
- 392
- Registration Number
- NCT04215120
- Locations
- 🇮🇳
Karnavati Hospital Pvt.Ltd, Ahmedabad, Gujarat, India
🇮🇳Chopda Medicare & Research Centre Pvt. Ltd, Nashik, Maharashtra, India
🇮🇳Star Hospital, Hyderabad, Telangana, India
Desidustat in the Treatment of Anemia in CKD
Phase 3
Completed
- Conditions
- Chronic Kidney Disease Stage 3AnemiaChronic Kidney Disease Stage 4Chronic Kidney Disease Stage 5
- Interventions
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- Zydus Lifesciences Limited
- Target Recruit Count
- 588
- Registration Number
- NCT04012957
- Locations
- 🇮🇳
Sawai Man Singh (SMS) Medical College and Hospital, Jaipur, Rajasthan, India
🇮🇳Max Super Specialty Hospital, New Delhi, Delhi, India
🇮🇳Eternal Hospital, Jaipur, Rajasthan, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath